Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2013 / Article

Research Article | Open Access

Volume 2013 |Article ID 787916 | https://doi.org/10.1155/2013/787916

Eric Diego Barioni, José Roberto Santin, Isabel Daufenback Machado, Stephen Fernandes de Paula Rodrigues, Viviane Ferraz-de-Paula, Theodoro Marcel Wagner, Bruno Cogliati, Matheus Corrêa dos Santos, Marina da Silva Machado, Sérgio Faloni de Andrade, Rivaldo Niero, Sandra Helena Poliselli Farsky, "Achyrocline satureioides (Lam.) D.C. Hydroalcoholic Extract Inhibits Neutrophil Functions Related to Innate Host Defense", Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 787916, 12 pages, 2013. https://doi.org/10.1155/2013/787916

Achyrocline satureioides (Lam.) D.C. Hydroalcoholic Extract Inhibits Neutrophil Functions Related to Innate Host Defense

Academic Editor: David Baxter
Received28 Nov 2012
Accepted31 Dec 2012
Published11 Feb 2013


Achyrocline satureioides (Lam.) D.C. is a herb native to South America, and its inflorescences are popularly employed to treat inflammatory diseases. Here, the effects of the in vivo actions of the hydroalcoholic extract obtained from inflorescences of A. satureioides on neutrophil trafficking into inflamed tissue were investigated. Male Wistar rats were orally treated with A. satureioides extract, and inflammation was induced one hour later by lipopolysaccharide injection into the subcutaneous tissue. The number of leukocytes and the amount of chemotactic mediators were quantified in the inflammatory exudate, and adhesion molecule and toll-like receptor 4 (TLR-4) expressions and phorbol-myristate-acetate- (PMA-) stimulated oxidative burst were quantified in circulating neutrophils. Leukocyte-endothelial interactions were quantified in the mesentery tissue. Enzymes and tissue morphology of the liver and kidney were evaluated. Treatment with A. satureioides extract reduced neutrophil influx and secretion of leukotriene B4 and CINC-1 in the exudates, the number of rolling and adhered leukocytes in the mesentery postcapillary venules, neutrophil L-selectin, β2-integrin and TLR-4 expression, and oxidative burst, but did not cause an alteration in the morphology and activities of liver and kidney. Together, the data show that A. satureioides extract inhibits neutrophil functions related to the innate response and does not cause systemic toxicity.

1. Introduction

Achyrocline satureioides (Lam.) D.C. is a herb native to South America. In Brazil, it predominantly occurs in southern regions, where it is popularly known as Marcela or Macela and is largely employed in folk medicine [1]. The ethnopharmacological use of infusions prepared from inflorescences of A. satureoides leads to the relief of symptoms of inflammatory disorders, asthma, anxiety, gastric ulcers, and other digestive diseases [27]. Investigations on its chemical composition showed that the extract obtained from inflorescences is rich in flavonoids, mainly quercetin and luteolin [1, 8, 9].

Experimental assays in vivo and in vitro have confirmed the ethnopharmacological employment of the extracts obtained from inflorescences of A. satureoides. In this context, the anti-inflammatory activity of aqueous and ethanolic extracts from A. satureoides in carrageenan-induced rat paw edema was shown [10], which may be correlated with the modulation of the innate immune response. Puhlmann and coauthors [11] showed enhanced in vivo phagocytic activity of carbon particles by macrophages obtained from rats treated with A. satureoides extract. In addition, A. satureoides infusion increased peripheral blood human mononuclear phytohemagglutinin- (PHA-) induced proliferation, interferon gamma (IFNγ), and interleukin-4 (IL-4) secretion [6, 11]. Although the anti-inflammatory effects of A. satureoides have been demonstrated, its direct actions on neutrophil functions have not been shown.

Neutrophils express a wide range of membrane receptors, such as adhesion molecules and chemoattractant receptors, prompting them to react to exogenous stimuli and endogenous chemical mediators. In this context, neutrophils express the toll-like receptor 4 (TLR-4), which is responsible for the recognition of lipopolysaccharides (LPSs) from Gram-negative bacteria. LPS binds to TLR-4 on the cell membrane and activates signal-transduction pathways, mainly via MyD88, which is a central adapter protein that leads to activation of the nuclear transcription factor factor-κB (NF-κB). NF-κB is the most important regulator of proinflammatory gene expression and induces a release of critical inflammatory molecules that are necessary to induce leukocyte migration into injured tissue and suitable immune responses [12, 13].

Leukocyte influx to the site of the inflammatory lesion is initially dependent on interactions between circulating cells and the endothelial cells of postcapillary venules, mediated by expression/activity of adhesion molecules on the surface of both cell types. L-selectin mediates the rolling of the neutrophils along endothelial cells, as it is rapidly expressed by activated neutrophils and interacts with constitutive carbohydrates or even with P- or E-selectin expressed on endothelial cells [14]. L-selectin is cleaved, by action of metalloproteases, pointing to the leukocytes become arrested to the endothelium [15]. Therefore, integrin family molecules, especially β2-integrin subfamily molecules, which are mostly expressed by leukocytes, mediate firm adhesion by interacting with a diversity of endothelial membrane components and immunoglobulin superfamily molecules. Ultimately, neutrophils transmigrate between interendothelial junctions, via heterophilic and homophilic interactions of immunoglobulin superfamily molecules, such as platelet endothelial cell adhesion molecule-1 (PECAM-1), to subsequently migrate to the inflammatory focus [16]. In the extravascular matrix, neutrophils directly move to the site of the lesion in response to chemotactic chemical mediators [17]. At the lesion site, they phagocyte the lesion-causing agent and release preformed chemical substances that contribute to the destruction of the damaging agent. However, in the case of noncontrolled inflammation, blockage of phases of neutrophil mobilization into focus of the inflammatory reaction is an important therapeutic strategy.

This study investigated the in vivo actions of hydroalcoholic extract obtained from inflorescences of A. satureoides on neutrophil trafficking from the blood into inflamed tissue. Data confirmed quercetin and luteolin to be the main constituents in the hydroalcoholic extract and showed the absence of systemic toxicity. However, results clearly showed that A. satureoides hydroalcoholic extract inhibits LPS-induced pathways of neutrophil migration via a mechanism that might be partially dependent on TLR-4 expression. Additional anti-inflammatory mechanisms might exist, as the extract also inhibited neutrophil activation caused by a direct intracellular stimulation of protein kinases.

2. Materials and Methods

2.1. Chemicals

Lipopolysaccharide from Escherichia coli (LPS, serotype 026:B6), indomethacin, EDTA, and propidium iodide (PI) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Ketamine and xylazine were purchased from Vetbrands (Paulinia, SP, Brazil), and heparin (Liquemine) was purchased from Roche Pharmaceuticals (Brazil). Anti-L-selectin-phycoerythrin (PE), anti-β2-integrin-fluorescein-isothiocyanate (FITC), Annexin-V-FITC, and anti-CD284/MD-2-PE (toll-like receptor 4) antibodies were obtained from BD Pharmingen (San Diego, CA, USA). Leukotriene B4 (LTB4) enzyme-linked immunosorbent assay (EIA) was obtained from GE Healthcare (Salt Lake City, UT, USA). The biochemical assays aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (gamma-GT), urea, and creatinine were purchased from Biotécnica (Varginha, MG, Brazil). Phorbol myristate acetate (PMA) was obtained from Calbiochem (San Diego, CA, USA), and 2′7′ dichlorodihydrofluorescein-diacetate (DCFH-DA) was obtained from Molecular Probes (Eugene, OR, USA). CINC-1 was also determined using EIA kits obtained from R&D Systems (Minneapolis, MN, USA). Air filters were purchased from TPP, Switzerland, and all reagents used in preparing the phosphate buffered solution (PBS) and ringer solution were purchased from Merck, USA.

2.2. Plant Material

Inflorescences of A. satureoides were collected in Fraiburgo, in the State of Santa Catarina, Brazil. The material was identified, and a voucher specimen was deposited at the herbarium of the State University of Maringá (UEM) with the code HUEM-23568. The material collection and all experiments were authorized by the Council of Management of Genetic Patrimony, Brazil (CGEN, process number 010062-2012-2). Air-dried plant material was cut into small pieces and macerated with 70% (v/v) aqueous ethanol at room temperature for 7 days. The macerate was filtered and the solvent removed by rotary evaporation under reduced pressure.

2.3. Apparatus and Chromatographic Conditions

Analysis was conducted using a high performance liquid chromatography (HPLC) system (Waters) equipped with a 600-F pump, 717 plus autosampler, followed by a line degasser (AF) and equipped with a UV-Vis detector (PDA 2996). A reverse-phase C18 column (25 cm, 4.6 mm i.d.; 0.5 μm film thickness and 100A) was employed (Luna, Phenomenex) at 25°C. Chromatographic separation was performed at room temperature with a flow rate 0.8 mL/min of gradient elution using two solvents: A (aqueous methanol, 50% (v/v)) and B (water acidified with acetic acid at pH 2.3). The gradient system used was 50% A (15 min), 50%–60% A (15 min), 60%–70% A (10 min), 70%–80% A (10 min), 80%–90% A (10 min), and 95% A (5 min). UV-Vis spectra were recorded at wavelengths 200–400 nm (detection at 350 nm). Solvents used were of HPLC grade, filtered (0.2 μm, Schleicher & Schuell, Maidstone, Kent, UK), and degassed by sonication before use. The samples of hydroalcoholic extract (0.54 mg/mL) and standard quercetin and luteolin (0.5 mg/mL) were dissolved in methanol and filtered through a 0.45 μm membrane filter, and 20 μL was analyzed in triplicate.

2.4. Gas Chromatography-Mass Spectrometry Analysis (GC-MS)

The GC-MS analysis was carried out using a Shimadzu Gas Chromatograph (Model QP-2010S series) equipped with an AOC-20i injector. The GC was equipped with a fused silica capillary column-TRX-1 (30 m × 0.25 mm), film thickness 0.1 μm. The oven temperature was maintained at 220°C for 5 min holding time and was then raised from 220 to 300°C at a rate of 20°C/min, then held for 2 min and raised further to 310°C at a rate of 10°C/min, and once more held at this temperature for 15 min, employing helium gas (99.999%) as a carrier gas at a constant flow rate of 0.80 mL/min. Hydroalcoholic extract of A. satureoides (1 μL) at a split ratio of 1 : 20 was injected. An MS transfer line temperature of 250°C was performed on a Shimadzu (Model QP-2010S series) coupled Gas Chromatograph equipped with an NIST08 Library software database. Mass spectra were taken at a 70 eV scanning rate of 1 scan/s. Identification of compounds was conducted using the database of the NIST08 Library. The mass spectrum of the individual unknown compounds was compared with that of known compounds stored in the software database Library.

2.5. Animals

Male Wistar rats (180–220 g) were obtained from the Central Animal House of the School of Pharmaceutical Sciences and Chemistry Institute of the University of São Paulo. The animals were housed in standard cages, at room temperature ( °C), with 12 h dark/light cycles, and supplemented with food and water ad libitum. All procedures were performed according to the Brazilian Society of Science of Laboratory Animal guidelines for the proper care and use of experimental animals, and the experiments were approved by the local ethics committee (protocol number CEUA/FCF/334). The animals were anesthetized before each experimental procedure with ketamine/xylazine (80 : 8 mg/kg i.p.), thus preventing stress. 5-6 animals were used in each assay.

2.6. Treatments

The doses used in this study were based on data previously published by Santin et al. [2], which, in turn, applied doses based on the traditional folk use of this plant. In this study, the extract was administered orally at 50, 100, and 250 mg/kg. Assays were carried out 1 or 2 hours after treatments.

2.7. In Vivo Leukocyte Migration: Air Pouch Model

Animals were anesthetized, and 10 mL of sterile air was injected subcutaneously into the dorsal region. After six days, the pouch was refilled with 10 mL air. On the tenth day following the first air injection, the animals were divided into six groups and received one of the following treatments by oral gavage: (1) sham; (2) vehicle (PBS/ethanol 10%); (3) indomethacin (30 mg/kg; positive control); or (4)–(6) A. satureoides (50, 100, or 250 mg/kg). After 1 h, LPS from E. coli (serotype 026:B6; 1 mg/2 mL PBS) was injected directly into the pouches. At 1 h or 4 h after the LPS injection, the animals were reanesthetized and sacrificed. The pouches were washed with 2 mL ice-cold PBS, and the total leukocyte number was determined using a Neubauer chamber. Differential cell counts were performed on smears stained with May-Grünwald-Giemsa.

2.8. Cell Viability and TLR-4 Expression by Flow Cytometry

Peripheral blood samples from male Wistar rats submitted to the air pouch model (after 1 h LPS injection) were obtained via abdominal aorta punctures. Heparin (5000 UI/mL) was used as an anticoagulant. Subsequently, the whole blood was hemolyzed (hypotonic lysis with NaCl solution at 0.2% and 1.6%) and centrifuged (5 min at 600 g) to obtain the leukocytes. The total number of leukocytes was quantified using a Neubauer chamber. Peripheral leukocytes (1 × 106 cells) were incubated with Annexin V conjugated to FITC (1 : 100) for 20 min, and PI (100 μg/mL) was added immediately to evaluate cell viability. To quantify TLR-4 expression, leukocytes (1 × 106 cells) were incubated with anti-CD284/MD-2 (TLR-4) monoclonal antibodies conjugated to PE (1 : 100) for 60 min at room temperature. Immediately after incubations, all the samples, except for Annexin V, were centrifuged (5 min, 600 g) and resuspended in PBS for analysis in the flow cytometer FACSCalibur (Immunocytometry System, San Jose, CA, USA). Data were obtained from 10,000 cells, and only the morphologically viable leukocytes were considered for analysis. The neutrophil population was characterized by different size and complexity parameters of different cell types detected by flow cytometry. The optical signals emitted were converted into electronic signals and were analyzed by FlowJo software (Tree Star, Inc., Ashland, TN, USA). Results of TLR-4 expression are presented as fluorescence units, and apoptosis and necrosis are shown as the percentage of Annexin V- or PI-positive cells.

2.9. Adhesion Molecule Expression and Oxidative Burst by Flow Cytometry

Male Wistar rats (not submitted to the air pouch model) were divided into three groups and received one of the following treatments by oral gavage: (1) sham (2) vehicle (PBS/ethanol 10%), or (3) A. satureoides (100 mg/kg). Circulating leukocytes (1 × 106) from the whole blood were collected as described in Section 2.8. To measure the adhesion molecules expression, cells were incubated with or without LPS (1 μg/mL) for 60 min at 37°C. Subsequently, the leukocyte suspension was washed with 1 mL ice-cold PBS. The supernatant was discarded, and leukocytes were incubated with monoclonal anti-CD62L antibodies conjugated to PE (1 : 100) and anti-CD18 conjugated to FITC (1 : 100), for 20 minutes at room temperature. To assess the leukocyte oxidative metabolism, leukocytes (1 × 106 cells) were incubated with 100 μL of PMA (100 ng), 200 μL of DCFH-DA (0.3 mM), and 700 μL of PBS for 30 min at 37°C.

Immediately after incubations, the samples were centrifuged (5 min, 600 g) and were resuspended in PBS for quantification by flow cytometry. The neutrophil population was characterized as described in Section 2.8. Results of oxidative metabolism are expressed as units of fluorescence, and data of adhesion molecules are expressed as the percentage of positive cells.

2.10. Intravital Microscopy

Rats were divided into three groups and received one of the following treatments by oral gavage: (1) sham (PBS), (2) vehicle (PBS/ethanol 10%), or (3) A. satureoides (100 mg/kg). The rats were anesthetized 1 h after the treatment, and 30 min later, the mesentery was surgically exteriorized. Animals were maintained on a board thermostatically controlled at 37°C, which included a transparent platform on which the tissue to be transilluminated was placed. The preparation was kept moist and warm by irrigating the tissue with a warmed (37°C) Ringer-Locke solution (154 mM NaCl, 5.6 mM KCl, 2 mM CaCl2 2H2O, 6 mM NaHCO3, 5 mM glucose and 1% (w/v) gelatin, and pH 7.2–7.4). The rate of solution outflow onto the exposed tissue was controlled to keep the preparation in continuous contact with a film of the solution. Transilluminated images were obtained by optical microscopy (Axioplan II, Carl-Zeiss equipped with 5.0/0.30 × Plan-Neofluar or 10.0/0.25 × Achroplan longitudinal distance objectives/numeric aperture and 1.0 × 1.25 × or 1.60 × Optovar). The images were captured by a video camera (ZVS, 3C75DE, Carl-Zeiss) and were transmitted simultaneously to a TV monitor and to a computer. Images obtained on the TV monitor were recorded on software. Digitized images on the computer monitor were subsequently analyzed by image analyzing software (AxioVision).

The interaction between leukocytes and the vessel walls was analyzed by determining the number of rolling and adherent leukocytes on the postcapillary venule wall (20–30 μm diameter, 200 μm length) of the mesentery. Leukocytes moving in the periphery of the axial stream, in contact with the endothelium, were considered to be rolling, and their number was determined in 10 min periods. The number of leukocytes that adhered to the endothelium (stopped at the vessel wall) was determined in the same vascular segment after 10 min. The number of rolling and adherent cells was quantified after topical application of LPS (30 μg/40 μL in PBS) to the venules of the mesentery microcirculation. Three fields were evaluated per animal after application. The results were then averaged for each animal.

2.11. Inflammatory Mediators

The air pouch lavage fluid was collected 1 h after LPS injection to evaluate the concentration of inflammatory mediators. LTB4 and CINC-1 were quantified using EIA Kits according to the manufacturer’s instructions. The results were expressed as pg/mL or ng/mL, respectively.

2.12. Biochemical Parameters

The whole blood was collected 2 hour after treatments without anticoagulant to serum separation after centrifugation (10 min, 600 g). The concentration of kidney and liver markers was analyzed using commercial biochemical kits for urea, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-GT.

2.13. Histopathology

Liver and kidney samples were collected 2 hour after treatments, washed with phosphate-buffered saline (PBS), and fixed in 10% buffered formalin for 24 hours. Tissue samples were dehydrated in graded ethanol solutions, cleared in xylene, and embedded in paraffin wax. After that, serial sections (5 μm) were prepared and stained with hematoxylin and eosin (H&E). Images were taken at original magnification of 100x (Eclipse E800 Microscope, Nikon, Japan).

2.14. Statistical Analysis

Means and the standard error of the mean (S.E.M.) for all data are presented and were compared using Student’s -tests or ANOVA. Tukey’s Multiple Comparisons test was performed to determine the significance of the differences between experimental conditions. GraphPad Prism 4.0 software (San Diego, CA, USA) was employed. Values of were considered significant.

3. Results

3.1. Chromatographic Analysis

The phytochemical profile of the A. satureoides hydroalcoholic extract showed six compounds, and two main compounds were identified (Figure 1(a)). The major components of the extract were compounds 1 and 2, which were identified by direct comparison with authentic samples and area peaks as luteolin and quercetin, respectively. Although these compounds occurred in other tissues of A. satureoides, the relative content of these two flavonoids from inflorescences was 12.31 and 13.65 μg/mL for 1 and 2, respectively. The GC-MS analysis showed seven distinct peaks, identified via the NIST08 library software database as ethyl ester derivatives of oleic, palmitic and stearic acids. In addition, the steroids stigmasterol, gamma-sitosterol, and sitostenone were also identified in the A. satureoides extract (Figure 1(b)).

3.2. A. satureoides Hydroalcoholic Extract Inhibits In Vivo Neutrophil Migration into LPS-Inflamed Tissue

The in vivo anti-inflammatory effect of the hydroalcoholic A. satureoides extract on LPS-induced inflammation in the subcutaneous tissue of rats (air pouch model) was investigated. Different doses were tested, and the number of cells migrating into the pouches was determined 4 h after injection of LPS or PBS. Results presented in Figure 2(a) show that A. satureoides treatment reduced leukocyte migration to the inflammatory site, which reflected an impaired influx of neutrophils (Figure 2(b)). The effect caused by 100 mg/Kg of A. satureoides extract was similar to that evoked by indomethacin treatment (Figures 2(a) and 2(b)).

Assays were conducted to evaluate the inhibitory mechanism of A. satureoides extract on cellular mechanisms involved in neutrophil migration to the site of the lesion. For this purpose, neutrophils were isolated from rats and incubated in vitro with the extract; thus, the direct action of the extract in each phase of neutrophil migration could be investigated. However, in vitro incubation with the extract caused cell death, especially by necrosis (data not shown). For this reason, all the following assays were conducted using blood and circulating leukocytes collected after in vivo vehicle or A. satureoides extract treatments.

3.3. A. satureoides Hydroalcoholic Extract In Vivo Treatment Does Not Affect Neutrophil Viability

Based on cell viability data obtained from in vitro studies, it was also relevant to investigate leukocyte viability from circulating blood following in vivo treatments with A. satureoides extract. Data presented in Table 1 show that extract treatment did not cause cell death, as determined by the Annexin V/PI labeled flow cytometry assay.

DoseALTASTGama-GTUrea Creatinine

Sham37.65 ± 1.96124.60 ± 9.469.04 ± 2.2037.02 ± 2.830.53 ± 0.08
Vehicle41.60 ± 2.57113.60 ± 17.453.25 ± 2.3433.59 ± 0.830.53 ± 0.41
A. satureoides 10035.07 ± 1.92106.60 ± 10.635.44 ± 2.1837.20 ± 2.570.35 ± 0.06

Data are expressed as mean ± S.E.M. of 6 animals in each group. Sham (air pouch induced without treatment). Statistical analysis was performed using ANOVA followed by Tukey’s test.

3.4. A. satureoides Hydroalcoholic Extract Impairs In Vivo Leukocyte-Endothelial Interactions

The behavior of leukocytes in the peripheral blood was evaluated by direct observation of the microcirculation network. Administration of A. satureoides extract slightly reduced the number of LPS-induced rolling leukocytes in comparison to the number observed in vehicle-treated rats (Figure 3(a)). However, administration of the extract markedly reduced the LPS-induced adherence of leukocytes to the vessel wall of the mesentery network (Figure 3(b)). It was further shown that A. satureoides extract did not induce toxicological effects on the microcirculation, such as hemorrhage, thrombus formation, or vascular stasis (data not shown).

3.5. A. satureoides Hydroalcoholic Extract Alters Neutrophil Adhesion Molecule Expression

Leukocyte-endothelial interaction is mediated by adhesion molecule expression. As A. satureoides extract reduced the in vivo leukocyte-endothelial interactions, assays were performed to investigate the actions of the extract on the expression of L-selectin and β2-integrin on the neutrophil surface. Results show that a dose of 100 mg/kg A. satureoides extract reduced the number of β2-integrin- (Figure 4(a)) and L-selectin-positive (Figure 4(b)) neutrophils after LPS stimulation, showing that treatment with the extract affected the ability of neutrophils to express both molecules.

3.6. A. satureoides Hydroalcoholic Extract Reduces CINC-1 and LTB-4 Secretion in LPS-Induced Inflamed Exudates

Chemical mediators including neutrophils are secreted in inflammatory condition by different cells. To investigate the ability of A. satureoides extract to inhibit the secretion of the chemotactic mediators CINC-1 and LTB-4, exudate was collected from animals treated with A. satureoides hydroalcoholic extract or vehicles, 1 h following LPS injection into the air pouch. This experimental strategy was employed to avoid large differences in the number of migrated leukocytes into air pouches, as observed 4 hours after LPS injection (Figure 2(b); vehicle: 92 × 106; A. satureoides; 25 × 106), which could be responsible for altered secretion of these chemokines. As shown in Figure 5(a), treatment with A. satureoides extract reduced neutrophil migration into the air pouch 1 hour after LPS injection (vehicle: 1.15 × 106; A. satureoides: 0.5 × 106) and decreased both LTB-4 and CINC-1 levels in the inflammatory exudate (Figures 5(b) and 5(c)).

3.7. A. satureoides Hydroalcoholic Extract Reduces TLR-4 Expression and PMA-Induced Oxidative Burst on Neutrophils

To elucidate the molecular mechanism of the anti-inflammatory effect shown by A. satureoides extract, membrane TLR-4 expression was evaluated by flow cytometry. The results showed that neutrophils obtained from animals orally treated with A. satureoides extract showed lower TLR-4 expression than animals treated with vehicle (Figure 6(a)). The reduction of TLR-4 expression might be totally or partially responsible for the anti-inflammatory activities observed in this study and might also suggest that this mechanism is a unique pathway of A. satureoides extract action. To investigate this hypothesis, neutrophils collected from treated rats were stimulated with PMA in vitro. PMA is lipophilic and directly stimulates the phosphorylation of PKC kinases, which are responsible for activation of the respiratory burst [18, 19]. Neutrophils from animals treated with A. satureoides extract and incubated with PMA for 30 min demonstrated a significant reduction in the production of PMA-stimulated reactive oxygen species (ROS), as measured by DCFH formation (Figure 6(b)).

3.8. A. satureoides Hydroalcoholic Extract Treatment Does Not Cause Systemic Toxicity

Liver and kidney biochemical and histological parameters were investigated in rats treated with vehicle or A. satureoides. Data showed that activities of the main hepatic enzymes, AST, ALT, and gamma-GT, as well as levels of creatinine and urea were equivalent in samples collected from rats treated with A. satureoides hydroalcoholic extract or vehicle (Table 2). Furthermore, no alteration in liver and kidney structures was observed in animals from both treatments (Figure 7).

DoseApoptotic Later apoptoticNecroticViable
(mg/kg)cells (%)cells (%)cells (%)cells (%)

Sham2.23 ± 0.396.90 ± 0.6913.13 ± 1.7970.12 ± 5.55
Vehicle1.31 ± 0.143.77 ± 0.1912.45 ± 1.1582.71 ± 1.38
A. satureoides 1000.82 ± 0.057.32 ± 0.5619.13 ± 1.2574.01 ± 2.38

Data are expressed as mean ± S.E.M. of 6 animals in each group. Sham (air pouch induced without treatment). Statistical analysis was performed using ANOVA followed by Tukey’s test.

4. Discussion

Neutrophils exert an important role in the induction of innate inflammatory reactions and in the transition between innate and immune responses. Therefore, in the case of exacerbated reactions, blockage of their functions represents a therapeutic strategy. Here, we show that in vivo treatment with A. satureoides inflorescence hydroalcoholic extract significantly impaired neutrophil migration into LPS-induced inflamed exudates, and effects on neutrophil migratory properties and secretion of chemotactic mediators might be involved in its anti-inflammatory action. Although expression of TLR-4, the main receptor for LPS binding, was reduced on the neutrophil membrane and might be responsible for the activity of A. satureoides extract in these cells, other forms of action might be involved, as a lower oxidative burst was observed following direct intracellular activation of PKC kinases in neutrophils.

Much evidence has shown that plant extracts containing flavonoids exert anti-inflammatory effects [2024]. Previous studies have shown that A. satureoides extracts contain luteolin and quercetin [1, 2, 8, 9], and here, HPLC analysis corroborated that the two flavonoids are the main compounds within the inflorescence extract; however, GC-MS analysis showed that the A. satureoides extract also contains steroids and fatty acids. Based on the anti-inflammatory effects of flavonoids, it is expected that A. satureoides inflorescence extract can reduce neutrophil influx. Here, we show for the first time that A. satureoides extract reduces in vivo LPS induced neutrophil migration, which might relate to reduced TLR-4 membrane expression and therefore corroborate the action of quercetin and luteolin on TLR-4 expression [2528]. LPS treatment induced TLR-4 expression, as visualized by enhanced membrane density in cells collected from vehicle-treated animals in comparison to those obtained from sham animals. TLR-4 expressions on cells collected from extract-treated rats were reduced. However, it is notable that reduced TLR-4 is not the only pathway of action of A. satureoides extract on neutrophils, as neutrophils collected from rats treated with A. satureoides extract showed a reduced oxidative burst elicited by in vitro PMA stimulation, which directly activates PKC phosphorylation and phagocyte NADPH oxidase, leading to the release of reactive metabolites [29].

Data in our study do not show the direct effect of A. satureoides extract on neutrophil function, as in vitro neutrophil incubation with hydroalcoholic extract caused necrosis, even at low concentrations (data not shown). Cell death was not detected in vehicle-incubated cells, excluding the action of alcohol in the toxic effect (data not shown). It is relevant here that cytotoxicity caused by in vitro incubation with flavonoids is not cited in the literature. Many in vitro experimental studies have shown the direct action of extracts containing flavonoids on neutrophil function, but this has not been associated with cell death [3033]. It is possible that the experimental conditions and technical approach to quantify cell death are responsible for divergent results. In the present study, flow cytometry quantification of Annexin-V- and PI-labeled neutrophils was used to detect cell membrane alterations, as modifications of the cell surface structure also alter the adhesion and locomotory response of neutrophils. Notably, in vivo extract treatment did not alter neutrophil viability, and subsequent assays were performed using this experimental strategy. Kinetic studies will be carried out to investigate the mechanisms in the absence of extract toxicity in vivo. In addition, the lack of functional or morphological alterations in kidney and liver following A. satureoides extract treatment strongly supports the absence of in vivo toxicity.

As previously mentioned, neutrophil migration is dependent on initial contact of neutrophils with the endothelial cells from postcapillary venules [14], and intravital microscopy assays allow the visualization of leukocyte behavior in the microcirculatory network [3436]. Data here clearly show that in vivo administration of the A. satureoides extract reduced the number of rolling and adhered leukocytes in LPS-stimulated mesentery. These data were further corroborated by the altered number of L-selectin- and β2-integrin-positive neutrophils, suggesting that in vivo extract treatment modifies the adhesive properties of neutrophils to the endothelium, which then impairs their migration into inflamed tissue. It has been shown that genetic deficiency of L-selectin or β2-integrin on leukocyte membranes reduces cell influx into inflamed areas, leading to accumulation of neutrophils in the blood [3739].

Leukocyte adhesion to endogenous substrates, such as endothelium and extravascular matrix constituents, and direct migration to the damage site are dependent on the interaction between chemotactic mediators and specific receptors, mainly those expressed on cell membranes which activate pathways involved in adhesion and migration [4043]. In this context, leukotriene B4 and CINC-1 are chemoattractants secreted by different cells in the inflammatory process, including migrated neutrophils, resident macrophages, mast cells, and fibroblasts [4448]. Data in this study show that in vivo treatment with A. satureoides extract reduced the amount of both mediators in the inflammation exudates, showing the ability of the extract to inhibit the secretion of inflammatory cells. The cells that are responsible for this reduced secretion have been not established; nevertheless, A. satureoides treatment might inhibit the secretory activity of resident cells in the subcutaneous tissue, as the reduced levels of chemoattractants were similar in exudates collected 1 or 4 h after LPS injections, irrespective of the number of neutrophils in the pouches.

Taken together, data presented here show the mechanisms of A. satureoides inflorescence extract on neutrophil influx using in vivo approaches, which might be responsible for the ethnopharmacological application of the extract. This might also be the mechanism involved in antiulcerogenic activity of the extract [2], as neutrophil influx into damaged stomachs is a hallmark of acute gastric disease.

5. Conclusions

Taken together, data presented here from different in vivo studies show the mechanisms of the anti-inflammatory effect of A. satureoides hydroalcoholic extract. Based on these findings, we have highlighted the inhibitory actions of A. satureoides hydroalcoholic extract on adhesive and migration properties, TLR-4 expression, and oxidative metabolism of neutrophils, which might contribute to its anti-inflammatory effects and help to explain the use of A. satureoides extract as a therapeutic agent.

Conflict of Interests

The authors declare that there is no conflict of interests.


The authors thank FAPESP for financial support (Grant no. 2011/15115-2). S. H. P. Farsky is a fellow of the Conselho Nacional de Pesquisa e Tecnologia (CNPq). E. D. Barioni, J. R. Santin, and I. D. Machado are postgraduate fellows of FAPESP. V. Ferraz-de-Paula and S. Fernandes de Paula Rodrigues are postdoctoral fellows of FAPESP. The authors thank the Neuroimmunomodulation Research Group for flow cytometry measurements (FAPESP no. 2009/51886-3).


  1. G. Ferraro, C. Anesini, A. Ouvina et al., “Total phenolic content and antioxidant activity of extracts of Achyrocline satureioides flowers from different zones in Argentina,” Latin American Journal of Pharmacy, vol. 27, no. 4, pp. 626–628, 2008. View at: Google Scholar
  2. J. R. Santin, M. Lemos, L. C. K. Júnior, R. Niero, and S. F. de Andrade, “Antiulcer effects of Achyrocline satureoides (Lam.) DC (Asteraceae) (Marcela), a folk medicine plant, in different experimental models,” Journal of Ethnopharmacology, vol. 130, no. 2, pp. 334–339, 2010. View at: Publisher Site | Google Scholar
  3. A. Gugliucci and T. Menini, “Three different pathways for human LDL oxidation are inhibited in vitro by water extracts of the medicinal herb Achyrocline satureoides,” Life Sciences, vol. 71, no. 6, pp. 693–705, 2002. View at: Publisher Site | Google Scholar
  4. C. Kadarian, A. M. Broussalis, J. Miño et al., “Hepatoprotective activity of Achyrocline satureioides (Lam) D. C,” Pharmacological Research, vol. 45, no. 1, pp. 57–61, 2002. View at: Publisher Site | Google Scholar
  5. M. F. Arredondo, F. Blasina, C. Echeverry et al., “Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress,” Journal of Ethnopharmacology, vol. 91, no. 1, pp. 13–20, 2004. View at: Publisher Site | Google Scholar
  6. M. Cosentino, R. Bombelli, E. Carcano et al., “Immunomodulatory properties of Achyrocline satureioides (Lam.) D.C. infusion: a study on human leukocytes,” Journal of Ethnopharmacology, vol. 116, no. 3, pp. 501–507, 2008. View at: Publisher Site | Google Scholar
  7. L. A. Del Vitto, E. M. Petenatti, M. E. Petenatti, S. M. Mazza, and E. J. Marchevsky, “Major and trace elements contents in crude drug and infusions of two South American species of Achyrocline (Asteraceae) named "marcelas",” Latin American Journal of Pharmacy, vol. 28, no. 4, pp. 552–559, 2009. View at: Google Scholar
  8. K. B. C. De Souza, V. L. Bassani, and E. E. S. Schapoval, “Influence of excipients and technological process on anti-inflammatory activity of quercetin and Achyrocline satureoides (Lam.) D.C. extracts by oral route,” Phytomedicine, vol. 14, no. 2-3, pp. 102–108, 2007. View at: Google Scholar
  9. J. M. Fachinetto, M. D. Bagatini, J. Durigon, A. C. F. Silva, and S. B. Tedesco, “Efeito anti-proliferativo das infusões de Achyrocline satureoides DC, (Asteraceae) sobre o ciclo celular de Allium cepa,” Revista Brasileira De Farmacognosia, vol. 17, no. 1, pp. 49–54, 2007. View at: Google Scholar
  10. C. M. Simoes, E. P. Schenkel, L. Bauer, and A. Langeloh, “Pharmacological investigations on Achyrocline satureioides (Lam.) DC., compositae,” Journal of Ethnopharmacology, vol. 22, no. 3, pp. 281–293, 1988. View at: Google Scholar
  11. J. Puhlmann, U. Knaus, L. Tubaro, W. Schaefer, and H. Wagner, “Immunologically active metallic ion-containing polysaccharides of Achyrocline satureioides,” Phytochemistry, vol. 31, no. 8, pp. 2617–2621, 1992. View at: Google Scholar
  12. J. C. Kagan and R. Medzhitov, “Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling,” Cell, vol. 125, no. 5, pp. 943–955, 2006. View at: Publisher Site | Google Scholar
  13. J. H. Peng, T. Cui, Z. L. Sun et al., “Effects of puerariae radix extract on endotoxin receptors and TNF-α expression induced by gut-derived endotoxin in chronic alcoholic liver injury,” Evidence Based in Complementary and Alternative Medicine, vol. 2012, Article ID 234987, 12 pages, 2012. View at: Publisher Site | Google Scholar
  14. C. E. Green, D. N. Pearson, R. T. Camphausen, D. E. Staunton, and S. I. Simon, “Shear-dependent capping of L-selectin and P-selectin glycoprotein ligand 1 by E-selectin signals activation of high-avidity β2-integrin on neutrophils,” Journal of Immunology, vol. 172, no. 12, pp. 7780–7790, 2004. View at: Google Scholar
  15. D. M. Smalley and K. Ley, “L-selectin: mechanisms and physiological significance of ectodomain cleavage,” Journal of Cellular and Molecular Medicine, vol. 9, no. 2, pp. 255–266, 2005. View at: Google Scholar
  16. K. Ley, C. Laudanna, M. I. Cybulsky, and S. Nourshargh, “Getting to the site of inflammation: the leukocyte adhesion cascade updated,” Nature Reviews Immunology, vol. 7, no. 9, pp. 678–689, 2007. View at: Publisher Site | Google Scholar
  17. C. N. Serhan, S. D. Brain, C. D. Buckley et al., “Resolution of inflammation: state of the art, definitions and terms,” The FASEB Journal, vol. 21, no. 2, pp. 325–332, 2007. View at: Publisher Site | Google Scholar
  18. M. A. Myers, L. C. McPhail, and R. Snyderman, “Redistribution of protein kinase C activity in human monocytes: correlation with activation of the respiratory burst,” Journal of Immunology, vol. 135, no. 5, pp. 3411–3416, 1985. View at: Google Scholar
  19. Y. Yasui, K. Yamada, S. Takahashi et al., “PMA induces GCMa phosphorylation and alters its stability via the PKC- and ERK-dependent pathway,” Biochemical and Biophysical Research Communications, vol. 417, no. 4, pp. 1127–1132, 2012. View at: Google Scholar
  20. A. R. Tapas, D. M. Sakarkar, and R. B. Kadke, “Flavonoids as nutraceuticals: a review,” Tropical Journal of Pharmaceutical Research, vol. 7, pp. 1089–1099, 2008. View at: Google Scholar
  21. A. García-Lafuente, E. Guillamón, A. Villares, M. A. Rostagno, and J. A. Martínez, “Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease,” Inflammation Research, vol. 58, no. 9, pp. 537–553, 2009. View at: Google Scholar
  22. C. R. Liao, Y. S. Chang, W. H. Peng, S. C. Lai, and Y. L. Ho, “Analgesic and anti-inflammatory activities of the methanol extract of Elaeagnus oldhamii Maxim. in mice,” American Journal of Chinese Medice, vol. 40, no. 3, pp. 581–597, 2012. View at: Google Scholar
  23. T. H. Quang, N. T. Ngan, C. V. Minh et al., “Anti-inflammatory and PPAR transactivational properties of flavonoids from the roots of Sophora flavescens,” Phytotherapy Research, 2012. View at: Publisher Site | Google Scholar
  24. B. T. Chen, W. X. Li, R. R. He et al., “Anti-inflammatory effects of a polyphenols-rich extract from tea (Camellia sinensis) flowers in acute and chronic mice models,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 537923, 7 pages, 2012. View at: Publisher Site | Google Scholar
  25. M. Kaneko, H. Takimoto, T. Sugiyama, Y. Seki, K. Kawaguchi, and Y. Kumazawa, “Suppressive effects of the flavonoids quercetin and luteolin on the accumulation of lipid rafts after signal transduction via receptors,” Immunopharmacology and Immunotoxicology, vol. 30, no. 4, pp. 867–882, 2008. View at: Publisher Site | Google Scholar
  26. J. K. Lee, S. Y. Kim, Y. S. Kim, W. H. Lee, D. H. Hwang, and J. Y. Lee, “Suppression of the TRIF-dependent signaling pathway of toll-like receptors by luteolin,” Biochemical Pharmacology, vol. 77, no. 8, pp. 1391–1400, 2009. View at: Publisher Site | Google Scholar
  27. S. Bhaskar, V. Shalini, and A. Helen, “Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway,” Immunobiology, vol. 216, no. 3, pp. 367–373, 2011. View at: Publisher Site | Google Scholar
  28. H. Qiao, X. Zhang, C. Zhu et al., “Luteolin downregulates TLR4, TLR5, NF-κB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia,” Brain Research, vol. 448, pp. 71–81, 2012. View at: Google Scholar
  29. H. Lundqvist, P. Follin, L. Khalfan, and C. Dahlgren, “Phorbol myristate acetate-induced NADPH oxidase activity in human neutrophils: only half the story has been told,” Journal of Leukocyte Biology, vol. 59, no. 2, pp. 270–279, 1996. View at: Google Scholar
  30. E. S. Suyenaga, E. L. Konrath, R. R. Dresch et al., “Appraisal of the antichemotactic activity of flavonoids on polymorphonuclear neutrophils,” Planta Medica, vol. 77, no. 7, pp. 698–704, 2011. View at: Publisher Site | Google Scholar
  31. M. Ciz, P. Denev, M. Kratchanova, O. Vasicek, G. Ambrozova, and A. Lojek, “Flavonoids inhibit the respiratory burst of neutrophils in mammals,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 181295, 6 pages, 2012. View at: Publisher Site | Google Scholar
  32. A. K. Kiss, A. Kapłon-Cieślicka, K. J. Filipiak, G. Opolski, and M. Naruszewicz, “Ex vivo effects of an Oenothera paradoxa extract on the reactive oxygen species generation and neutral endopeptidase activity in neutrophils from patients after acute myocardial infarction,” Phytotherapy Research, vol. 26, no. 4, pp. 482–487, 2012. View at: Google Scholar
  33. H. R. Liao, J. J. Chen, Y. H. Chien, S. Z. Lin, S. Lin, and C. P. Tseng, “5-Hydroxy-7-methoxyflavone inhibits N-formyl-L-methionyl-L-leucyl-L-phenylalanine-induced superoxide anion production by specific modulate membrane localization of Tec with a PI3K independent mechanism in human neutrophils,” Biochemical Pharmacology, vol. 84, no. 2, pp. 182–191, 2012. View at: Google Scholar
  34. S. H. P. Farsky, P. Borelli, R. A. Fock, S. Z. Proto, J. M. C. Ferreira Jr., and S. B. V. Melo, “Chronic blockade of nitric oxide biosynthesis in rats: effect on leukocyte endothelial interaction and on leukocyte recruitment,” Inflammation Research, vol. 53, no. 9, pp. 442–452, 2004. View at: Publisher Site | Google Scholar
  35. C. B. de Lima, E. K. Tamura, T. Montero-Melendez et al., “Actions of translocator protein ligands on neutrophil adhesion and motility induced by G-protein coupled receptor signaling,” Biochemical and Biophysical Research Communications, vol. 417, no. 2, pp. 918–923, 2012. View at: Google Scholar
  36. F. N. Gavins, “Intravital microscopy: new insights into cellular interactions,” Current Opinion of Pharmacology, vol. 12, no. 5, pp. 601–607, 2012. View at: Google Scholar
  37. E. Van de Vijver, A. Maddalena, Ö. Sanal et al., “Hematologically important mutations: leukocyte adhesion deficiency (first update),” Blood Cells and Molecular Disease, vol. 15, no. 1, pp. 53–61, 2012. View at: Google Scholar
  38. Y. Shimada, M. Hasegawa, Y. Kaburagi et al., “L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity,” Journal of Immunology, vol. 170, no. 8, pp. 4325–4334, 2003. View at: Google Scholar
  39. Y. Li, J. Brazzell, A. Herrera, and B. Walcheck, “ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding,” Blood, vol. 108, no. 7, pp. 2275–2279, 2006. View at: Publisher Site | Google Scholar
  40. S. I. Simon and C. E. Green, “Molecular mechanics and dynamics of leukocyte recruitment during inflammation,” Annals Review of Biomedical Engineering, vol. 7, pp. 151–185, 2005. View at: Google Scholar
  41. S. Y. Yuan, Q. Shen, R. R. Rigor, and M. H. Wu, “Neutrophil transmigration, focal adhesion kinase and endothelial barrier function,” Microvascular Research, vol. 83, no. 1, pp. 82–88, 2012. View at: Google Scholar
  42. M. J. Sanz and P. Kubes, “Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking,” European Journal of Immunology, vol. 42, no. 2, pp. 278–283, 2012. View at: Google Scholar
  43. S. D. Chase, J. L. Magnani, and S. I. Simon, “E-selectin ligands as mechanosensitive receptors on neutrophils in health and disease,” Annals of Biomedical Engineering, vol. 40, no. 4, pp. 849–859, 2012. View at: Google Scholar
  44. J. Palmblad, “The role of granulocytes in inflammation,” Scandinavian Journal of Rheumatology, vol. 13, no. 2, pp. 163–172, 1984. View at: Google Scholar
  45. E. J. Leonard and T. Yoshimura, “Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]),” American Journal of Respiratory Cell and Molecular Biology, vol. 2, no. 6, pp. 479–486, 1990. View at: Google Scholar
  46. S. Koyama, E. Sato, H. Numanami, K. Kubo, S. Nagai, and T. Izumi, “Bradykinin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity,” American Journal of Respiratory Cell and Molecular Biology, vol. 22, no. 1, pp. 75–84, 2000. View at: Google Scholar
  47. J. Witowski, H. Tayama, K. Ksiek, M. Wanic-Kossowska, T. O. Bender, and A. Jörres, “Human peritoneal fibroblasts are a potent source of neutrophil-targeting cytokines: a key role of IL-1beta stimulation,” Laboratory Investigation, vol. 89, no. 4, pp. 414–424, 2009. View at: Publisher Site | Google Scholar
  48. Z. Weng, B. Zhang, S. Asadi et al., “Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans,” PLoS One, vol. 7, no. 3, Article ID e33805, 2012. View at: Google Scholar

Copyright © 2013 Eric Diego Barioni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.